nodes	percent_of_prediction	percent_of_DWPC	metapath
Penbutolol—HTR1B—Serotonin receptors—HTR2A—conduct disorder	0.061	0.0648	CbGpPWpGaD
Penbutolol—ORM1—saliva—conduct disorder	0.0466	0.797	CbGeAlD
Penbutolol—HTR1A—Serotonin receptors—HTR2A—conduct disorder	0.0465	0.0494	CbGpPWpGaD
Penbutolol—HTR1B—Monoamine GPCRs—DRD4—conduct disorder	0.0416	0.0442	CbGpPWpGaD
Penbutolol—HTR1B—Amine ligand-binding receptors—DRD4—conduct disorder	0.035	0.0372	CbGpPWpGaD
Penbutolol—ADRB1—Monoamine GPCRs—DRD4—conduct disorder	0.0332	0.0352	CbGpPWpGaD
Penbutolol—ADRB2—Monoamine GPCRs—DRD4—conduct disorder	0.0324	0.0345	CbGpPWpGaD
Penbutolol—HTR1A—Monoamine GPCRs—DRD4—conduct disorder	0.0317	0.0337	CbGpPWpGaD
Penbutolol—ADRB1—Melatonin metabolism and effects—MAOA—conduct disorder	0.0294	0.0313	CbGpPWpGaD
Penbutolol—ADRB1—Amine ligand-binding receptors—DRD4—conduct disorder	0.0279	0.0296	CbGpPWpGaD
Penbutolol—ADRB2—Amine ligand-binding receptors—DRD4—conduct disorder	0.0273	0.029	CbGpPWpGaD
Penbutolol—HTR1B—Monoamine GPCRs—HTR2A—conduct disorder	0.0272	0.0289	CbGpPWpGaD
Penbutolol—HTR1A—Amine ligand-binding receptors—DRD4—conduct disorder	0.0267	0.0283	CbGpPWpGaD
Penbutolol—HTR1B—Amine ligand-binding receptors—HTR2A—conduct disorder	0.0228	0.0243	CbGpPWpGaD
Penbutolol—ADRB1—Monoamine GPCRs—HTR2A—conduct disorder	0.0216	0.023	CbGpPWpGaD
Penbutolol—ADRB2—Monoamine GPCRs—HTR2A—conduct disorder	0.0212	0.0225	CbGpPWpGaD
Penbutolol—HTR1A—Monoamine GPCRs—HTR2A—conduct disorder	0.0207	0.022	CbGpPWpGaD
Penbutolol—ADRB1—G alpha (s) signalling events—CGA—conduct disorder	0.0205	0.0218	CbGpPWpGaD
Penbutolol—ADRB2—G alpha (s) signalling events—CGA—conduct disorder	0.0201	0.0213	CbGpPWpGaD
Penbutolol—ADRB1—Amine ligand-binding receptors—HTR2A—conduct disorder	0.0182	0.0193	CbGpPWpGaD
Penbutolol—ADRB2—Amine ligand-binding receptors—HTR2A—conduct disorder	0.0178	0.0189	CbGpPWpGaD
Penbutolol—HTR1A—Amine ligand-binding receptors—HTR2A—conduct disorder	0.0174	0.0185	CbGpPWpGaD
Penbutolol—ADRB2—GPCRs, Other—DRD4—conduct disorder	0.0144	0.0153	CbGpPWpGaD
Penbutolol—HTR1B—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.0123	0.0131	CbGpPWpGaD
Penbutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00979	0.0104	CbGpPWpGaD
Penbutolol—HTR1A—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.00974	0.0103	CbGpPWpGaD
Penbutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00958	0.0102	CbGpPWpGaD
Penbutolol—ADRB2—GPCRs, Other—HTR2A—conduct disorder	0.0094	0.00999	CbGpPWpGaD
Penbutolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00937	0.00995	CbGpPWpGaD
Penbutolol—HTR1B—GPCR ligand binding—CGA—conduct disorder	0.00936	0.00994	CbGpPWpGaD
Penbutolol—HTR1B—G alpha (i) signalling events—DRD4—conduct disorder	0.00866	0.0092	CbGpPWpGaD
Penbutolol—HTR1B—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00804	0.00854	CbGpPWpGaD
Penbutolol—ADRB1—GPCR ligand binding—CGA—conduct disorder	0.00746	0.00792	CbGpPWpGaD
Penbutolol—HTR1A—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.00733	0.00778	CbGpPWpGaD
Penbutolol—ADRB2—GPCR ligand binding—CGA—conduct disorder	0.00729	0.00775	CbGpPWpGaD
Penbutolol—HTR1A—GPCR ligand binding—CGA—conduct disorder	0.00713	0.00758	CbGpPWpGaD
Penbutolol—HTR1B—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00689	0.00731	CbGpPWpGaD
Penbutolol—HTR1A—G alpha (i) signalling events—DRD4—conduct disorder	0.0066	0.00701	CbGpPWpGaD
Penbutolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.0064	0.0068	CbGpPWpGaD
Penbutolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00626	0.00665	CbGpPWpGaD
Penbutolol—HTR1A—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00612	0.0065	CbGpPWpGaD
Penbutolol—HTR1A—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.00597	0.00634	CbGpPWpGaD
Penbutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00548	0.00582	CbGpPWpGaD
Penbutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00536	0.0057	CbGpPWpGaD
Penbutolol—HTR1B—GPCR downstream signaling—CGA—conduct disorder	0.00529	0.00562	CbGpPWpGaD
Penbutolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00525	0.00557	CbGpPWpGaD
Penbutolol—HTR1B—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00524	0.00557	CbGpPWpGaD
Penbutolol—HTR1B—GPCR ligand binding—DRD4—conduct disorder	0.00524	0.00557	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—CGA—conduct disorder	0.00481	0.0051	CbGpPWpGaD
Penbutolol—HTR1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00449	0.00477	CbGpPWpGaD
Penbutolol—HTR1B—brain—conduct disorder	0.00432	0.0739	CbGeAlD
Penbutolol—ADRB1—GPCR downstream signaling—CGA—conduct disorder	0.00421	0.00448	CbGpPWpGaD
Penbutolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00418	0.00444	CbGpPWpGaD
Penbutolol—ADRB1—GPCR ligand binding—DRD4—conduct disorder	0.00418	0.00444	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—CGA—conduct disorder	0.00412	0.00438	CbGpPWpGaD
Penbutolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00409	0.00434	CbGpPWpGaD
Penbutolol—ADRB2—GPCR ligand binding—DRD4—conduct disorder	0.00409	0.00434	CbGpPWpGaD
Penbutolol—ADRB1—brain—conduct disorder	0.00406	0.0696	CbGeAlD
Penbutolol—HTR1A—GPCR downstream signaling—CGA—conduct disorder	0.00403	0.00428	CbGpPWpGaD
Penbutolol—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00399	0.00424	CbGpPWpGaD
Penbutolol—HTR1A—GPCR ligand binding—DRD4—conduct disorder	0.00399	0.00424	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—CGA—conduct disorder	0.00383	0.00406	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—CGA—conduct disorder	0.00374	0.00398	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—CGA—conduct disorder	0.00366	0.00389	CbGpPWpGaD
Penbutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00358	0.0038	CbGpPWpGaD
Penbutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.0035	0.00372	CbGpPWpGaD
Penbutolol—HTR1A—brain—conduct disorder	0.00349	0.0597	CbGeAlD
Penbutolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00342	0.00363	CbGpPWpGaD
Penbutolol—HTR1B—GPCR ligand binding—HTR2A—conduct disorder	0.00342	0.00363	CbGpPWpGaD
Penbutolol—HTR1A—SIDS Susceptibility Pathways—EP300—conduct disorder	0.00317	0.00336	CbGpPWpGaD
Penbutolol—HTR1B—GPCR downstream signaling—DRD4—conduct disorder	0.00296	0.00315	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—CGA—conduct disorder	0.00284	0.00301	CbGpPWpGaD
Penbutolol—ADRB1—GPCR ligand binding—HTR2A—conduct disorder	0.00272	0.00289	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—DRD4—conduct disorder	0.00269	0.00286	CbGpPWpGaD
Penbutolol—ADRB2—GPCR ligand binding—HTR2A—conduct disorder	0.00267	0.00283	CbGpPWpGaD
Penbutolol—HTR1A—GPCR ligand binding—HTR2A—conduct disorder	0.00261	0.00277	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—DRD4—conduct disorder	0.00236	0.00251	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—DRD4—conduct disorder	0.00231	0.00245	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—WASF1—conduct disorder	0.00227	0.00242	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—CGA—conduct disorder	0.00226	0.0024	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—DRD4—conduct disorder	0.00226	0.0024	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CGA—conduct disorder	0.00221	0.00235	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CGA—conduct disorder	0.00216	0.0023	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—DRD4—conduct disorder	0.00214	0.00228	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—DRD4—conduct disorder	0.0021	0.00223	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—DRD4—conduct disorder	0.00205	0.00218	CbGpPWpGaD
Penbutolol—HTR1B—GPCR downstream signaling—HTR2A—conduct disorder	0.00193	0.00205	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—WASF1—conduct disorder	0.00181	0.00192	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—WASF1—conduct disorder	0.00177	0.00188	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—HTR2A—conduct disorder	0.00176	0.00186	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—WASF1—conduct disorder	0.00173	0.00184	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—DRD4—conduct disorder	0.00159	0.00169	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—HTR2A—conduct disorder	0.00154	0.00164	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—HTR2A—conduct disorder	0.00151	0.0016	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—HTR2A—conduct disorder	0.00147	0.00156	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—HTR2A—conduct disorder	0.0014	0.00149	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—HTR2A—conduct disorder	0.00137	0.00145	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—HTR2A—conduct disorder	0.00134	0.00142	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—DRD4—conduct disorder	0.00127	0.00134	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—DRD4—conduct disorder	0.00124	0.00132	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—DRD4—conduct disorder	0.00121	0.00129	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—HTR2A—conduct disorder	0.00104	0.0011	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—HTR2A—conduct disorder	0.000826	0.000877	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—HTR2A—conduct disorder	0.000808	0.000858	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—HTR2A—conduct disorder	0.00079	0.000839	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—EP300—conduct disorder	0.000549	0.000584	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—EP300—conduct disorder	0.000438	0.000465	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—EP300—conduct disorder	0.000428	0.000455	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—EP300—conduct disorder	0.000419	0.000445	CbGpPWpGaD
